KRYS
Price
$148.39
Change
+$3.58 (+2.47%)
Updated
Jan 17 closing price
Capitalization
4.27B
44 days until earnings call
MIST
Price
$1.98
Change
+$0.02 (+1.02%)
Updated
Jan 17 closing price
Capitalization
105.59M
73 days until earnings call
Ad is loading...

KRYS vs MIST

Header iconKRYS vs MIST Comparison
Open Charts KRYS vs MISTBanner chart's image
Krystal Biotech
Price$148.39
Change+$3.58 (+2.47%)
Volume$180.09K
Capitalization4.27B
Milestone Pharmaceuticals
Price$1.98
Change+$0.02 (+1.02%)
Volume$211.4K
Capitalization105.59M
KRYS vs MIST Comparison Chart
Loading...
KRYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MIST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KRYS vs. MIST commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KRYS is a Hold and MIST is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (KRYS: $148.39 vs. MIST: $1.98)
Brand notoriety: KRYS and MIST are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KRYS: 66% vs. MIST: 43%
Market capitalization -- KRYS: $4.27B vs. MIST: $105.59M
KRYS [@Biotechnology] is valued at $4.27B. MIST’s [@Biotechnology] market capitalization is $105.59M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KRYS’s FA Score shows that 1 FA rating(s) are green whileMIST’s FA Score has 0 green FA rating(s).

  • KRYS’s FA Score: 1 green, 4 red.
  • MIST’s FA Score: 0 green, 5 red.
According to our system of comparison, both KRYS and MIST are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KRYS’s TA Score shows that 4 TA indicator(s) are bullish while MIST’s TA Score has 3 bullish TA indicator(s).

  • KRYS’s TA Score: 4 bullish, 4 bearish.
  • MIST’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, both KRYS and MIST are a good buy in the short-term.

Price Growth

KRYS (@Biotechnology) experienced а -2.96% price change this week, while MIST (@Biotechnology) price change was -4.81% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

KRYS is expected to report earnings on May 12, 2025.

MIST is expected to report earnings on May 19, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KRYS($4.27B) has a higher market cap than MIST($106M). KRYS YTD gains are higher at: -5.279 vs. MIST (-16.102). KRYS has higher annual earnings (EBITDA): 181M vs. MIST (-39.14M). KRYS has more cash in the bank: 588M vs. MIST (76.4M). KRYS has less debt than MIST: KRYS (7.48M) vs MIST (54M). KRYS has higher revenues than MIST: KRYS (242M) vs MIST (0).
KRYSMISTKRYS / MIST
Capitalization4.27B106M4,026%
EBITDA181M-39.14M-462%
Gain YTD-5.279-16.10233%
P/E Ratio83.37N/A-
Revenue242M0-
Total Cash588M76.4M770%
Total Debt7.48M54M14%
FUNDAMENTALS RATINGS
KRYS: Fundamental Ratings
KRYS
OUTLOOK RATING
1..100
68
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
PROFIT vs RISK RATING
1..100
25
SMR RATING
1..100
80
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KRYSMIST
RSI
ODDS (%)
Bullish Trend 11 days ago
79%
Bearish Trend 11 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 11 days ago
74%
Bearish Trend 11 days ago
77%
Momentum
ODDS (%)
Bearish Trend 11 days ago
81%
Bullish Trend 11 days ago
73%
MACD
ODDS (%)
Bullish Trend 11 days ago
81%
Bullish Trend 11 days ago
75%
TrendWeek
ODDS (%)
Bullish Trend 11 days ago
77%
Bearish Trend 11 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 11 days ago
75%
Bullish Trend 11 days ago
81%
Advances
ODDS (%)
Bullish Trend about 1 month ago
76%
Bullish Trend 19 days ago
82%
Declines
ODDS (%)
Bearish Trend 17 days ago
76%
N/A
BollingerBands
ODDS (%)
N/A
Bearish Trend 11 days ago
79%
Aroon
ODDS (%)
Bearish Trend 11 days ago
81%
N/A
View a ticker or compare two or three
Ad is loading...
KRYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MIST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
HEWJ41.770.42
+1.01%
iShares Currency Hedged MSCI Japan ETF
NULG87.580.79
+0.91%
Nuveen ESG Large-Cap Growth ETF
RZG51.090.26
+0.50%
Invesco S&P SmallCap 600® Pure Gr ETF
XHYD37.860.08
+0.22%
BondBloxx US HY Cnsmr N-Cyclcls Sctr ETF
CADJPY107.91N/A
N/A
Canadian Dollar - Japan Yen

KRYS and

Correlation & Price change

A.I.dvisor indicates that over the last year, KRYS has been loosely correlated with CLDX. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if KRYS jumps, then CLDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KRYS
1D Price
Change %
KRYS100%
+2.47%
CLDX - KRYS
57%
Loosely correlated
+4.48%
BEAM - KRYS
47%
Loosely correlated
+0.17%
ZLDPF - KRYS
45%
Loosely correlated
+1.17%
ALT - KRYS
45%
Loosely correlated
+2.24%
VCYT - KRYS
44%
Loosely correlated
-1.27%
More